| 查看: 419 | 回复: 0 | |||
[交流]
请问慢乙肝的病人敢用苯溴马隆吗
|
|
如题,病人别嘌醇0.1 bid 后尿酸仍在五百多,现在建议苯溴马隆口服,但是查了资料说赛诺菲已经在03年因为苯溴马隆的肝损召回了,没有这方面的经验,请指教。 http://apps.who.int/medicinedocs/en/d/Js4947e/1.4.html 这是WHO的关于苯溴马隆召回的材料。 BENZ-BROMARONE - Withdrawn due to reports of liver damage France. Sanofi-Synthélabo has withdrawn its hyperuricaemic product benzbromarone (Desuric) in France following reports of serious liver damage associated with the product's use. Benzbromarone (Desuric) has been marketed in France since 1976, but rare reports of serious cytolytic liver damage, including fatal cases and others requiring liver transplants, have led to an unfavourable benefit/risk ratio. The company has therefore decided to stop the marketing of this product in France and to recall all stocks. Reference: Chaibriant H. Stop marketing of proprietary medical product DESURIC (Rm) (benzbromarone), 22 Apr 2003. Available from URL: http://agmed.sante.gouv.fr |
» 猜你喜欢
论文投稿被拒,想argue,各位大神有相关经验么
已经有16人回复
对于文章里面引用别人芯片数据的相关问题
已经有5人回复
循环系统论文润色/翻译怎么收费?
已经有154人回复
医学类sci三审将近2个月了还在peer review
已经有7人回复
这种情况建议催稿吗?
已经有3人回复
第一次sci投稿,大修后小修,下面是审稿人的意见,接收概率有多大?
已经有12人回复
sci论文小修编辑没给审稿意见!
已经有13人回复
临床医学复试调剂 一志愿温州医科大学 321分
已经有0人回复
有虫友做过材料表面氨基化后酰胺化反应连接肝素或其他带有羧基的嘛
已经有4人回复
国自然
已经有9人回复













回复此楼